Long-acting calcium channel antagonist pranidipine prevents ventricular remodeling after myocardial infarction in rats

Heart and Vessels

Volumn 14, Issue 3, 1999, Pages 111-119

  Takeuchi, Kazuhide ^a   Omura, Takashi ^a   Yoshiyama, Minoru ^a   Yoshida, Ken ^a   Otsuka, Ryo ^a   Shimada, Yoshihisa ^a   Ujino, Keiji ^a   Yoshikawa, Junichi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Calcium channel antagonist; Echocardiography; Gene expression; Myocardial infarction; Ventricular remodeling

Indexed keywords

ACTIN; ADRENALIN; ATRIAL NATRIURETIC FACTOR; CALCIUM CHANNEL; DOPAMINE; HUMORAL ANTIBODY; MESSENGER RNA; MYOSIN HEAVY CHAIN; NORADRENALIN; PRANIDIPINE; RENIN;

ADRENALIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; CORONARY ARTERY; DIASTOLE; DOPAMINE BLOOD LEVEL; GENE EXPRESSION REGULATION; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE POTENTIAL; HEART VENTRICLE REMODELING; HEART WEIGHT; HEMODYNAMICS; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; SYSTOLE;

EID: 0033406731     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02482294     Document Type: Article

References (40)

1. Weisman HF, Bush DE, Mannisi JA, Bulkley BH (1985) Global cardiac remodeling after acute myocardial infarction: a study in the rat model. J Am Coll Cardiol 5:1355
2. McKay RG, Pfeffer MA, Pasternak RC, Markis JE, Come PC, Nakao S, Alderman JD, Ferguson JJ, Safian RD, Grossman W (1986) Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation 74:693
3. Pfeffer MA, Braunwald E (1990) Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81:1161
4. Yoshiyama M, Takeuchi K, Omura T, Kim S, Yamagishi H, Toda I, Teragaki M, Akioka K, Iwao H, Yoshikawa J (1999) Effects of candesartan and cilazapril on rats with myocardial infarction assessed by echocardiography. Hypertension 33:961
5. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P (1985) Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 72:406
6. SAVE (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327:669
7. SOLVD (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 325:293
8. CONSENSUS (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 316:1429
9. Packer M, O'Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, Miller AB, Neuberg GW, Frid D, Wertheimer JH, Cropp AB, DeMets DL (1996) Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med 335:1107
10. Shimada T, Yoshiyama M, Takeuchi K, Omura T, Takemoto Y, Kim S, Iwao H, Yoshikawa J (1998) Long acting calcium antagonist amlodipine prevents left ventricular remodeling after myocardial infarction in rats. Cardiovasc Res 37:618
11. Murdoch D, Heel RC (1991) Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs 41:478
12. Little WC, Cheng CP (1994) Vascular versus myocardial effects of calcium antagonists. Drugs 4:41
13. Conti CR (1994) Use of calcium antagonists to treat heart failure. Clin Cardiol 17:101
14. Uehara Y, Kawabata Y, Hirawa N, Takada S, Numabe A, Matsuoka H, Ikeda T, Takabatake Y, Yagi S, Sugimoto T (1992) OPC-13340, a new dihydropyridine calcium channel blocker attenuates rapid vascular smooth muscle cell growth in spontaneously hypertensive rats. J Cardiovasc Pharmacol 20:408
15. Rosenthal J, Hittel N, Stumpe KO (1996) Pranidipine, a novel calcium antagonist, once daily, for the treatment of hypertension: a multicenter, double-blind, placebo-controlled dose-finding study. Cardiovasc Drugs Ther 10:59
16. 2+ channel antagonist, in rats: comparison with nifedipine and amlodipine. Eur J Pharmacol 324:201
17. Nakayama N, Ikezono K, Mori T, Yamashita S, Nakayama S, Tanaka Y, Hosokawa T, Minami Y, Masutani K, Yamamura Y, Yabuuchi Y (1990) Antihypertensive activity of OPC-13340, a new potent and long-acting dihydropyridine calcium antagonist, in rats. J Cardiovasc Pharmacol 15:836
18. Litwin SE, Katz SE, Morgan JP, Douglas PS (1994) Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation 89:345
19. Sahn DJ, DeMaria A, Kisslo J, Weyman A (1978) Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072
20. Gay RG (1990) Early and late effects of captopril treatment after large myocardial infarction in rats. J Am Coll Cardiol 16:967
21. Kim S, Ohta K, Hamaguchi A, Yukimura T, Miura K, Iwao H (1995) Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats. Hypertension 25:1252
22. Genovese C, Rowe D, Kream B (1984) Construction of DNA sequences complementary to rat alpha 1 and alpha 2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D. Biochemistry 23:6210
23. Liau G, Yamada Y, de Crambugghe B (1985) Coordinate regulation of the levels of type III and type I collagen mRNA in most but not all mouse fibroblasts. J Biol Chem 260:531
24. Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K, Inada Y, Wada T, Ishimura Y, Chatani F, Iwao H (1994) Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 24:195
25. MDPIT (1988) The effect of diltiazem on mortality and reinfarction after myocardial infarction. The Multicenter Diltiazem Postinfarction Trial Research Group. N Engl J Med 319:385
26. Gibson RS (1989) Current status of calcium channel-blocking drugs after Q wave and non-Q wave myocardial infarction. Circulation 80:107
27. Goldstein RE, Boccuzzi SJ, Cruess D, Nattel S (1991) Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group. Circulation 83:52
28. Iriarte M, Murga N, Sagastagoitia D, Molinero E, Morillas M, Salcedo A, Estella P, Etxebeste J (1993) Congestive heart failure from left ventricular diastolic dysfunction in systemic hypertension. Am J Cardiol 71:308
29. Gaasch WH (1994) Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction. JAMA 271:1276
30. Giannuzzi P, Imparato A, Temporelli PL, de-Vito F, Silva PL, Scapellato F, Giordano A (1994) Doppler-derived mitral deceleration time of early filling as a strong predictor of pulmonary capillary wedge pressure in postinfarction patients with left ventricular systolic dysfunction. J Am Coll Cardiol 23:1630
31. Xie GY, Berk MR, Smith MD, Gurley JC, DeMaria AN (1994) Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. J Am Coll Cardiol 24:132
32. Hanatani A, Yoshiyama M, Kim S, Omura T, Toda I, Akioka K, Teragaki M, Takeuchi K, Iwao H, Takeda T (1995) Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction. J Mol Cell Cardiol 27:1905
33. Chassagne C, Wisnewsky C, Schwartz K (1993) Antithetical accumulation of myosin heavy chain but not alpha-actin mRNA isoforms during early stages of pressure-overload-induced rat cardiac hypertrophy. Circ Res 72:857
34. Schiaffino S, Samuel JL, Sassoon D, Lompre AM, Garner I, Marotte F, Buckingham M, Rappaport L, Schwartz K (1989) Nonsynchronous accumulation of alpha-skeletal actin and beta-myosin heavy chain mRNAs during early stages of pressure-overload-induced cardiac hypertrophy demonstrated by in situ hybridization. Circ Res 64:937
35. Swynghedauw B (1986) Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles. Physiol Rev 66:710
36. Hewett TE, Grupp IL, Grupp G, Robbins J (1994) Alpha-skeletal actin is associated with increased contractility in the mouse heart. Circ Res 74:740
37. Izumo S, Nadal GB, Mahdavi V (1988) Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci USA 85:339
38. Weber KT, Janicki JS, Shroff SG, Pick R, Chen RM, Bashey RI (1988) Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ Res 62:757
39. Volders PG, Willems IE, Cleutjens JP, Arends JW, Havenith MG, Daemen MJ (1993) Interstitial collagen is increased in the non-infarcted human myocardium after myocardial infarction. J Mol Cell Cardiol 25:1317
40. Weber KT, Sun Y, Tyagi SC, Cleutjens JP (1994) Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 26:279